Evaluation of Albumin Creatinine Ratio as a Screening Test in Diabetic Patients

被引:0
作者
Priya, V. Sri Lakshmi [1 ]
Subhashree, A. R. [1 ]
Parijatham, B. O. [1 ]
机构
[1] Sree Balaji Med Coll & Hosp, Dept Pathol, Madras 44, Tamil Nadu, India
来源
RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES | 2016年 / 7卷 / 01期
关键词
Diabetes mellitus; Albumin Creatinine Ratio; screening test;
D O I
暂无
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Microalbuminuria is an early sign of renal disease in individuals with Diabetes.lt is established as a marker of diabetic nephropathy. In this study we compared spot urine albumin in the form of Albumin Creatinine ratio (A:Cratio) with 24 hours urine urine albumin excretion method.Random urine samples and 24 hr collection were obtained from 100 Diabetic patients. Albumin creatinine ratio was calculated from the spot urine specimens.From 24 hour urine samples albumin excretion rate was calculated. Results of albumin/creatinine ratio were then compared to the 24 hr urine albumin excretion rate. Measurements of Urine albumin and UACR in a spot urine specimen presented almost perfect accuracy for the screening of micro and macro albunninuria and RUS is simpler and less expensive. It is suggested as a valid screening test for diabetic nephropathy
引用
收藏
页码:95 / 98
页数:4
相关论文
共 6 条
[1]  
Kumar KS, 2012, PHARM INNOVATION, V1, P18
[2]   National kidney foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification [J].
Levey, AS ;
Coresh, J ;
Balk, E ;
Kausz, AT ;
Levin, A ;
Steffes, MW ;
Hogg, RJ ;
Perrone, RD ;
Lau, J ;
Eknoyan, G .
ANNALS OF INTERNAL MEDICINE, 2003, 139 (02) :137-147
[3]  
Mohan V, 2007, INDIAN J MED RES, V125, P217
[4]  
Powers AC, 2008, HARRISONS PRINCIPLES, V17th, P2275
[5]   Type 2 diabetes and diabetic nephropathy in India - magnitude of the problem [J].
Viswanathan, V .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (12) :2805-2807
[6]   Global prevalence of diabetes - Estimates for the year 2000 and projections for 2030 [J].
Wild, S ;
Roglic, G ;
Green, A ;
Sicree, R ;
King, H .
DIABETES CARE, 2004, 27 (05) :1047-1053